Evidence map›Paper›PMID 26940059›Full record

ReviewCurrent oncology reports2016

Brachytherapy in Gynecologic Cancers: Why Is It Underused?

Kathy Han, Akila N Viswanathan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current oncology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Survey on brachytherapy training among radiation oncology residents in the German-speaking regions of Europe.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Article
  4. Global challenges of radiotherapy for the treatment of locally advanced cervical cancer.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2022
    Review
  5. Practical brachytherapy solutions to an age-old quandary.Technical innovations & patient support in radiation oncology · 2020
    Review
  6. Global Collaborations for Cervical Cancer: Can the East-West Alliance Facilitate Treatment for all?Clinical oncology (Royal College of Radiologists (Great Britain)) · 2019
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Kathy HanDepartment of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Akila N ViswanathanDepartment of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, 75 Francis Street, ASB1-L2, Boston, MA, 02115, USA. akila@post.harvard.edu.
Dana-Farber Brigham Cancer Center · USUniversity of Toronto · CA

Funding

PHS HHS R21 167800
6 · The paper itself

Abstract

Despite its established efficacy, brachytherapy is underused in the management of cervical and vaginal cancers in some parts of the world. Possible reasons for the underutilization of brachytherapy include the adoption of less invasive techniques, such as intensity-modulated radiotherapy; reimbursement policies favoring these techniques over brachytherapy; poor physician or patient access to brachytherapy; inadequate maintenance of brachytherapy skills among practicing radiation oncologists; transitioning to high-dose-rate (HDR) brachytherapy with increased time requirements; and insufficient training of radiation oncology residents.

Indexed as

BrachytherapyCombined Modality TherapyFemaleGenital Neoplasms, FemaleHumansRadiotherapy DosageRadiotherapy, Intensity-ModulatedUterine Cervical NeoplasmsVaginal NeoplasmsBrachytherapyCervical cancerGynecologic cancerIntensity-modulated radiotherapyUtilizationVaginal cancer

Identifiers

PMID26940059
OpenAlexW2288855485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.